Skip to Main Content

Paper Details

Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.
Ann Oncol
3
2017
Author NameAffiliation
F??tima Al-ShahrourSpanish National Cancer Research Centre (CNIO)
  • 1 - 1

Datasets

Release 1.2